{
  "ticker": "REGN",
  "last_updated": "2025-04-15T14:53:27.739286",
  "retention_years": 3,
  "count": 277,
  "transactions": [
    {
      "id": 113208,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "1",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "18846"
    },
    {
      "id": 113240,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-07-03",
      "transaction_shares": "250",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "20303"
    },
    {
      "id": 113178,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-06-01",
      "transaction_shares": "250",
      "transaction_price": "736.0",
      "transaction_type": "S",
      "shares_after_transaction": "20553"
    },
    {
      "id": 113225,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "2",
      "transaction_price": "730.03",
      "transaction_type": "S",
      "shares_after_transaction": "18945"
    },
    {
      "id": 113223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-05-15",
      "transaction_shares": "53807",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 113163,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2023-05-09",
      "transaction_shares": "1326",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "59421"
    },
    {
      "id": 113235,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "16",
      "transaction_price": "802.67",
      "transaction_type": "S",
      "shares_after_transaction": "19031"
    },
    {
      "id": 113173,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-21",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 72317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "7",
      "transaction_price": "816.58",
      "transaction_type": "S",
      "shares_after_transaction": "19140"
    },
    {
      "id": 72338,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-04-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 72339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "259",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "125493"
    },
    {
      "id": 113230,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "7",
      "transaction_price": "816.58",
      "transaction_type": "S",
      "shares_after_transaction": "19140"
    },
    {
      "id": 113253,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-04-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 113254,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "259",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "125493"
    },
    {
      "id": 72293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-03-27",
      "transaction_shares": "800",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "32905"
    },
    {
      "id": 113203,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-03-27",
      "transaction_shares": "800",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "32905"
    },
    {
      "id": 72316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-24",
      "transaction_shares": "1240",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2487"
    },
    {
      "id": 113229,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-24",
      "transaction_shares": "1240",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2487"
    },
    {
      "id": 72269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-03-23",
      "transaction_shares": "2192",
      "transaction_price": "806.47",
      "transaction_type": "S",
      "shares_after_transaction": "18409"
    },
    {
      "id": 72289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-03-23",
      "transaction_shares": "254",
      "transaction_price": "800.59",
      "transaction_type": "S",
      "shares_after_transaction": "200250"
    },
    {
      "id": 72330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-23",
      "transaction_shares": "25000",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "312578"
    },
    {
      "id": 72343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-23",
      "transaction_shares": "10000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "34213"
    },
    {
      "id": 113179,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-03-23",
      "transaction_shares": "2192",
      "transaction_price": "806.47",
      "transaction_type": "S",
      "shares_after_transaction": "18409"
    },
    {
      "id": 113199,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-03-23",
      "transaction_shares": "254",
      "transaction_price": "800.59",
      "transaction_type": "S",
      "shares_after_transaction": "200250"
    },
    {
      "id": 113245,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-23",
      "transaction_shares": "25000",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "312578"
    },
    {
      "id": 113258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-23",
      "transaction_shares": "10000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "34213"
    },
    {
      "id": 72280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-10",
      "transaction_shares": "1006",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 113190,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-10",
      "transaction_shares": "1006",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 72281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-03-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 72344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-01",
      "transaction_shares": "5",
      "transaction_price": "758.2",
      "transaction_type": "S",
      "shares_after_transaction": "19242"
    },
    {
      "id": 113191,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-03-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 113259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-01",
      "transaction_shares": "5",
      "transaction_price": "758.2",
      "transaction_type": "S",
      "shares_after_transaction": "19242"
    },
    {
      "id": 72287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-22",
      "transaction_shares": "42500",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "366583"
    },
    {
      "id": 113197,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-22",
      "transaction_shares": "42500",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "366583"
    },
    {
      "id": 72257,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-12",
      "transaction_shares": "1276",
      "transaction_price": "751.78",
      "transaction_type": "F",
      "shares_after_transaction": "20803"
    },
    {
      "id": 113165,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-12",
      "transaction_shares": "1276",
      "transaction_price": "751.78",
      "transaction_type": "F",
      "shares_after_transaction": "20803"
    },
    {
      "id": 72276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-07",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23079"
    },
    {
      "id": 113186,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-07",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23079"
    },
    {
      "id": 72279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-02-06",
      "transaction_shares": "13189",
      "transaction_price": "800.08",
      "transaction_type": "S",
      "shares_after_transaction": "200504"
    },
    {
      "id": 72301,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3613",
      "transaction_price": "482.68",
      "transaction_type": "M",
      "shares_after_transaction": "9860"
    },
    {
      "id": 72329,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3071",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4318"
    },
    {
      "id": 113189,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-02-06",
      "transaction_shares": "13189",
      "transaction_price": "800.08",
      "transaction_type": "S",
      "shares_after_transaction": "200504"
    },
    {
      "id": 113212,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3613",
      "transaction_price": "482.68",
      "transaction_type": "M",
      "shares_after_transaction": "9860"
    },
    {
      "id": 113244,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3071",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4318"
    },
    {
      "id": 72271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-03",
      "transaction_shares": "1021",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2268"
    },
    {
      "id": 72292,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-02-03",
      "transaction_shares": "5000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "23581"
    },
    {
      "id": 72314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-02-03",
      "transaction_shares": "739",
      "transaction_price": "764.5",
      "transaction_type": "S",
      "shares_after_transaction": "32105"
    },
    {
      "id": 113181,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-03",
      "transaction_shares": "1021",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2268"
    },
    {
      "id": 113202,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-02-03",
      "transaction_shares": "5000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "23581"
    },
    {
      "id": 113227,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-02-03",
      "transaction_shares": "739",
      "transaction_price": "764.5",
      "transaction_type": "S",
      "shares_after_transaction": "32105"
    },
    {
      "id": 72299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-01",
      "transaction_shares": "2",
      "transaction_price": "752.11",
      "transaction_type": "S",
      "shares_after_transaction": "19345"
    },
    {
      "id": 72327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 113210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-01",
      "transaction_shares": "2",
      "transaction_price": "752.11",
      "transaction_type": "S",
      "shares_after_transaction": "19345"
    },
    {
      "id": 113242,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 72331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "1248"
    },
    {
      "id": 113246,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "1248"
    },
    {
      "id": 40261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-06",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 72325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-06",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 113239,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-06",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 40211,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "14",
      "transaction_price": "721.48",
      "transaction_type": "S",
      "shares_after_transaction": "19268"
    },
    {
      "id": 40212,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 40218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2037"
    },
    {
      "id": 40222,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6247"
    },
    {
      "id": 40227,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-01-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 40228,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 40230,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 40234,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26214"
    },
    {
      "id": 40250,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 40251,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 40254,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "40",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "319"
    },
    {
      "id": 40257,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1258"
    },
    {
      "id": 72260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "14",
      "transaction_price": "721.48",
      "transaction_type": "S",
      "shares_after_transaction": "19268"
    },
    {
      "id": 72261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 72267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2037"
    },
    {
      "id": 72273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6247"
    },
    {
      "id": 72282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-01-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 72283,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 72285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 72291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26214"
    },
    {
      "id": 72311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 72312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 72318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "40",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "319"
    },
    {
      "id": 72321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1258"
    },
    {
      "id": 113168,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "14",
      "transaction_price": "721.48",
      "transaction_type": "S",
      "shares_after_transaction": "19268"
    },
    {
      "id": 113169,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 113176,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2037"
    },
    {
      "id": 113183,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6247"
    },
    {
      "id": 113192,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-01-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 113193,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 113195,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 113201,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26214"
    },
    {
      "id": 113222,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 113224,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 113231,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "40",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "319"
    },
    {
      "id": 113234,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1258"
    },
    {
      "id": 40260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 72324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 113238,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 40208,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 72256,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 113164,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 40217,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 40221,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 40226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 40247,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 40249,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 40258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 40265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 40266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 72266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 72272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 72278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 72308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 72310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 72322,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 72333,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 72334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 113175,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 113182,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 113188,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 113219,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 113221,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 113236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 113248,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 113249,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 40213,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 40219,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 40225,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 40240,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 40241,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 72262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 72268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 72277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 72300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 72302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 113170,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 113177,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 113187,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 113211,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 113213,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 40235,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 40246,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 72294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 72307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 113204,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 113218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 40232,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 40239,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 40271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 72298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 72341,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113198,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 113209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 113256,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 72345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 113260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 40269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 72337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 113252,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 40229,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 40244,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 72284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 72305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 113194,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 113216,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 40243,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 40259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 72304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 72323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 113215,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 113237,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 40252,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 40264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 72332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 113247,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 72335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 113250,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 40268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 72336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 113251,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 20273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 40238,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 72297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 113207,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 20263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 20264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 20276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 20280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 40214,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 40215,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 40253,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 40263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 72263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 72264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 72315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 72328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 113171,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 113172,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 113228,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 113243,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 20265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 40216,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 72265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 113174,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 20268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 20270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 40224,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 40233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 72275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 72290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 113185,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 113200,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 20261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 40209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 72258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 113166,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 20267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 20275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 40223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 40248,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 72274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 72309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 113184,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 113220,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 20262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113167,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 40262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 72326,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 113241,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 20271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 40236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 72295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 113205,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 20278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 40256,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 72320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 113233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 20282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113257,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 7144,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40231,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113196,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 7145,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40237,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72296,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113206,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40245,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-24",
      "transaction_shares": "23077",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "322489"
    },
    {
      "id": 72306,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-24",
      "transaction_shares": "23077",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "322489"
    },
    {
      "id": 113217,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-24",
      "transaction_shares": "23077",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "322489"
    },
    {
      "id": 7146,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 20274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 40242,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 72303,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 113214,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 7147,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 7148,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 20281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40255,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 40270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 72340,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113232,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 113255,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    }
  ]
}